Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study.
Buerger
K
K
Memory Clinic, Alzheimer Memorial Center, Department of Psychiatry, Ludwig Maximilian University, Munich, Germany. katharina.buerger@med.uni-muenchen.de
Ewers
M
M
Andreasen
N
N
Zinkowski
R
R
Ishiguro
K
K
Vanmechelen
E
E
Teipel
S J
SJ
Graz
C
C
Blennow
K
K
Hampel
H
H
D000368:Aged; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid* / Q000175:diagnosis* / Q000523:psychology; D015415:Biomarkers / Q000134:cerebrospinal fluid; D001921:Brain / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D003072:Cognition Disorders / Q000134:cerebrospinal fluid* / Q000175:diagnosis* / Q000523:psychology; D018450:Disease Progression; D000939:Epitopes / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D010766:Phosphorylation; D011237:Predictive Value of Tests; D011379:Prognosis; D012307:Risk Factors; D016875:tau Proteins / Q000134:cerebrospinal fluid*
D015415:Biomarkers; D000939:Epitopes; D016875:tau Proteins